MWM
ABBV icon

Moran Wealth Management’s AbbVie ABBV Stock Holding History

Moran Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Buy
+1,863
New +$401K 0.01% 425
2023
Q3 		– Sell
-3,718
Closed -$501K – 368
2023
Q2 		$501K Sell
3,718
-1,199
-24% -$176K 0.02% 304
2023
Q1 		$784K Sell
4,917
-128,986
-96% -$19.7M 0.03% 272
2022
Q4 		$21.6M Buy
+133,903
New +$20.5M 0.82% 28

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Moran Wealth Management's ABBV Position: Q2 2026 in Review

Moran Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 1,863 shares worth $469K. The stake represents 0.01% of the portfolio and ranks #425 among its holdings. This is a return to the name: Moran Wealth Management previously reported a position in ABBV as recently as Q2 2023.

Moran Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 4 quarters since. The position peaked at $21.6M in Q4 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Moran Wealth Management held 1,863 shares of AbbVie worth $469K as of Q2 2026.
  • AbbVie was a new Moran Wealth Management position in Q2 2026.
  • AbbVie made up 0.01% of Moran Wealth Management's portfolio in Q2 2026, its #425 holding.
  • Moran Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 4 quarters since.
  • Moran Wealth Management's AbbVie position peaked at $21.6M in Q4 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.